Patents by Inventor Lucile Serfass

Lucile Serfass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease
    Publication number: 20100260667
    Abstract: Disclosed are methods for detecting multidrug resistance in neoplastic or damaged cells or multidrug resistant (MDR) neoplastic or damaged cells by detecting an increase in the cell surface expression of vimentin protein in such cells as compared to the level of cell surface expression of vimentin protein in a normal cell or a non-MDR neoplastic cell.
    Type: Application
    Filed: October 29, 2008
    Publication date: October 14, 2010
    Inventors: Elias Georges, Lucile Serfass, Anne-Marie Bonneau, Frédéric Dallaire
  • Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
    Patent number: 7670604
    Abstract: Disclosed are methods for treating or preventing a neoplastic or a multidrug resistant neoplasm in a subject using cell surface vimentin targeted therapeutic agents.
    Type: Grant
    Filed: July 1, 2005
    Date of Patent: March 2, 2010
    Assignee: Aurelium Biopharma, Inc.
    Inventors: Elias Georges, Lucile Serfass, Anne-Marie Bonneau, Frédéric Dallaire
  • Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
    Patent number: 7550256
    Abstract: Disclosed are methods for detecting multidrug resistance in neoplastic or damaged cells or multidrug resistant (MDR) neoplastic or damaged cells by detecting an increase in the cell surface expression of vimentin protein in such cells as compared to the level of cell surface expression of vimentin protein in a normal cell or a non-MDR neoplastic cell.
    Type: Grant
    Filed: December 15, 2003
    Date of Patent: June 23, 2009
    Assignee: Aurelium Biopharma, Inc.
    Inventors: Elias Georges, Lucile Serfass, Anne-Marie Bonneau, Frédéric Dallaire
  • HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
    Publication number: 20090004102
    Abstract: Disclosed are methods for detecting neoplastic or damaged cells and for detecting multidrug resistance in neoplastic or damaged cells by detecting an increase in the cell surface expression of a heat shock cognate (HSC70) protein 70 on the surface of such a multidrug resistant neoplastic or damaged cells as compared to the level of expression of the HSC70 protein on the surface of a normal cell.
    Type: Application
    Filed: May 9, 2007
    Publication date: January 1, 2009
    Applicant: Aurelium BioPharma Inc.
    Inventors: Elias Georges, Anne-Marie Bonneau, Frederic Dallaire, Lucile Serfass
  • Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
    Patent number: 7413851
    Abstract: Disclosed are methods for detecting neoplastic or damaged cells and for detecting multidrug resistance in neoplastic or damaged cells by detecting an increase in the cell surface expression of a nucleophosmin (NPM) protein on the surface of such a multidrug resistant neoplastic or damaged cells as compared to the level of expression of the nucleophosmin protein on the surface of a normal cell.
    Type: Grant
    Filed: December 15, 2003
    Date of Patent: August 19, 2008
    Assignee: Aurelium Biopharma, Inc.
    Inventors: Elias Georges, Lucile Serfass, Anne-Marie Bonneau, Frédéric Dallaire
  • Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
    Patent number: 7358042
    Abstract: Disclosed are methods for detecting neoplastic or damaged cells and for detecting multidrug resistance in neoplastic or damaged cells by detecting an increase in the cellular expression of a triosephosphate isomerase (TPI) protein in a multidrug resistant neoplastic or damaged cells as compared to the level of expression of the triosephosphate isomerase protein in a normal cell.
    Type: Grant
    Filed: March 15, 2004
    Date of Patent: April 15, 2008
    Assignee: Aurelium Biopharma, Inc.
    Inventors: Elias Georges, Lucile Serfass, Anne-Marie Bonneau, Frédéric Dallaire
  • HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
    Patent number: 7226748
    Abstract: Disclosed are methods for detecting neoplastic or damaged cells and for detecting multidrug resistance in neoplastic or damaged cells by detecting an increase in the cell surface expression of a heat shock cognate (HSC70) protein 70 on the surface of such a multidrug resistant neoplastic or damaged cells as compared to the level of expression of the HSC70 protein on the surface of a normal cell.
    Type: Grant
    Filed: December 15, 2003
    Date of Patent: June 5, 2007
    Assignee: Aurelium BioPharma, Inc.
    Inventors: Elias Georges, Lucile Serfass, Anne-Marie Bonneau, Frédéric Dallaire
  • Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
    Publication number: 20060014225
    Abstract: Disclosed are methods for treating or preventing a neoplastic or a multidrug resistant neoplasm in a subject using cell surface vimentin targeted therapeutic.
    Type: Application
    Filed: July 1, 2005
    Publication date: January 19, 2006
    Inventors: Elias Georges, Lucile Serfass, Anne-Marie Bonneau, Frederic Dallaire
  • Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
    Publication number: 20050026231
    Abstract: Disclosed are methods for detecting neoplastic or damaged cells and for detecting multidrug resistance in neoplastic or damaged cells by detecting an increase in the cellular expression of a triosephosphate isomerase (TPI) protein in a multidrug resistant neoplastic or damaged cells as compared to the level of expression of the triosephosphate isomerase protein in a normal cell.
    Type: Application
    Filed: March 15, 2004
    Publication date: February 3, 2005
    Inventors: Elias Georges, Lucile Serfass, Anne-Marie Bonneau, Frederic Dallaire
  • Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
    Publication number: 20050009119
    Abstract: Disclosed are methods for detecting neoplastic or damaged cells and for detecting multidrug resistance in neoplastic or damaged cells by detecting an increase in the cell surface expression of a nucleophosmin (NPM) protein on the surface of such a multidrug resistant neoplastic or damaged cells as compared to the level of expression of the nucleophosmin protein on the surface of a normal cell.
    Type: Application
    Filed: December 15, 2003
    Publication date: January 13, 2005
    Inventors: Elias Georges, Lucile Serfass, Anne-Marie Bonneau, Frederic Dallaire
  • Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
    Publication number: 20040259112
    Abstract: Disclosed are methods for detecting multidrug resistance in neoplastic or damaged cells or multidrug resistant (MDR) neoplastic or damaged cells by detecting an increase in the cell surface expression of vimentin protein in such cells as compared to the level of cell surface expression of vimentin protein in a normal cell or a non-MDR neoplastic cell.
    Type: Application
    Filed: December 15, 2003
    Publication date: December 23, 2004
    Applicant: Aurelium BioPharma Inc.
    Inventors: Elias Georges, Lucile Serfass, Anne-Marie Bonneau, Frederic Dallaire
  • HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
    Publication number: 20040185511
    Abstract: Disclosed are methods for detecting neoplastic or damaged cells and for detecting multidrug resistance in neoplastic or damaged cells by detecting an increase in the cell surface expression of a heat shock cognate (HSC70) protein 70 on the surface of such a multidrug resistant neoplastic or damaged cells as compared to the level of expression of the HSC70 protein on the surface of a normal cell.
    Type: Application
    Filed: December 15, 2003
    Publication date: September 23, 2004
    Applicant: Aurelium BioPharma, Inc.
    Inventors: Elias Georges, Lucile Serfass, Anne-Marie Bonneau, Frederic Dallaire